Jordan Johnson, Founder and Principal at Bridge Oncology and Legal Data Expert, shared on LinkedIn:
“The future of oncology will not be built by individual service lines operating independently. It will be built by organizations that can integrate clinical care, operations, technology, reimbursement strategy, and governance into a single coordinated oncology enterprise.
For too long, oncology has operated in silos. Radiation oncology, medical oncology, infusion, pharmacy, imaging, theranostics, revenue cycle, compliance, and physician operations have often been managed independently despite caring for the same patients. That model is becoming increasingly difficult to sustain as reimbursement changes, operational pressures grow, and expectations for quality and efficiency continue to rise.
That is why I am excited to welcome Lynn Whitehair, as Director of Oncology Services at Bridge Oncology.
Lynn brings decades of executive oncology leadership and operational experience that perfectly complements the clinical, reimbursement, compliance, legal, and strategy expertise our team has developed over the years. Her addition significantly strengthens our ability to help hospitals, health systems, and physician groups build integrated oncology programs that improve patient access, enhance operational performance, and prepare organizations for the next generation of cancer care.
Bridge Oncology has never viewed oncology through the lens of a single department. We believe the future belongs to organizations that can connect medical oncology, radiation oncology, infusion, pharmacy, theranostics, technology, AI, revenue integrity, and enterprise strategy into one coordinated system focused on better patient outcomes and sustainable operations.
Healthcare is changing rapidly, and oncology is changing even faster. We are continuing to build a team capable of helping organizations navigate that future – not simply react to it.”
Other articles featuring Jordan Johnson on OncoDaily.